Boehringer Ingelheim Venture - aVenture Asset Manager Research
Location
Ingelheim am Rhein, Rhineland-Palatinate, DE
Founded
2010
Boehringer Ingelheim Venture Fund is the strategic venture arm of Boehringer Ingelheim Corporation, focusing on pioneering scientific innovations with the potential to significantly benefit patients. The firm invests globally across various stages, including Seed, Series A, Series B, and Series C rounds, typically engaging in Series A and B investments. Their portfolio companies span diverse sectors within the life sciences industry.
Notable portfolio companies include Actym Therapeutics, Hookipa Pharma, and Viron, which have raised substantial capital. The fund is led by a team of experienced professionals who bring deep expertise in corporate restructuring and acquisitions. Boehringer Ingelheim Venture Fund offers unique value-add services to its portfolio companies, leveraging its extensive network and resources to support growth and innovation.
Boehringer Ingelheim Venture - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
